Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated

NACompletedINTERVENTIONAL
Enrollment

288

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Prostate Cancer
Interventions
RADIATION

Hypofractionated IMRT boost radiotherapy

All patients included into this arm are irradiated to 46 Gy a 2 Gy fraction to the whole pelvis and seminal vesicles and prostate gland (I phase) and than the boost dose is limited to the prostate gland with some part of seminal vesicles with hypofractionated dose of 7.5 Gy in two fractions (II phase) to the total dose of 61 Gy. Additionally all patients received neoadjuvant Androgen Deprivation Therapy (3-4 months prior starting radiotherapy) and during radiotherapy and during the follow-up up to 24 months.

RADIATION

Conventional Fractionated IMRT boost radiotherapy

All patients included into this arm are irradiated to 46 Gy a 2 Gy fraction to the whole pelvis and seminal vesicles and prostate gland (I phase) and than the boost dose is limited to the prostate gland with some part of seminal vesicles with conventional fractionated dose of 2 Gy in 15 fractions (II phase) to the total dose of 76 Gy. Additionally all patients received neoadjuvant Androgen Deprivation Therapy (3-4 months prior starting radiotherapy) and during radiotherapy and during the follow-up up to 24 months.

Trial Locations (3)

53-413

Lower-Silesian Oncology Centre, Wroclaw

10-228

Independent Public Healthcare of Ministry of Interior with Warmia and Mazury Oncology Centre, Olsztyn

61-866

Greater Poland Cancer Centre, Poznan

All Listed Sponsors
lead

The Greater Poland Cancer Centre

OTHER

NCT02300389 - Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated | Biotech Hunter | Biotech Hunter